MEX Equity Snapshot

GILD Weekly Equity Report

Gilead Sciences, Inc.

Interactive chart JSON snapshot
Latest Close 2,117 MXN 12 Jun 2026
1W Return -6.4% latest completed week
4W Return -6.9% short-term follow-through
12W Return -16.2% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
Company Brief

What the company does

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment …

Snapshot

What the weekly tape is saying

GILD closed the latest completed week at 2,117 MXN. The 4-week return is -6.9% and the 12-week return is -16.2%. Trend Signal is inactive, Market Dynamics is -1.01. Setup signature: Risk-first tape with a 26/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -10.3%
Volume 0.4x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 35 Persistence of active Trend Signal over the last year and current streak.
Momentum 20 Blend of 4-week and 12-week follow-through.
Dynamics 32 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 6 Relative leadership and short-term RS change.
Volume 15 Participation compared with the 13-week volume baseline.
Risk Control 48 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
2,361 MXN
Vs Trend Line
-10.3%
Fair Value
1,783 MXN
Vs Fair Value
18.7%
52W High
2,618 MXN
52W Low
2,024 MXN
Drawdown
-19.1%
Range Position
15.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -6.4%
4W -6.9%
12W -16.2%
26W -4.3%
52W 1.6%

Trend read

Active Streak
0 weeks
52W Active Weeks
33
52W Active Breadth
63.5%
Sector Scope
MX Healthcare
Sector Rank
71 of 78
Sector Percentile
9.1%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.01
4W MD Change
7.1%
Relative Strength
-12.14
4W RS Change
-96.7%
Expectation
Undecided
Probability
50.92%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
202
13W Average
567
52W Average
1.8K
Vs 13W
0.4x
Vs 52W
0.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.6%
52W Volatility
3.3%
Upside Weeks
24
Downside Weeks
20
Downside Breadth
38.5%
Avg Gain / Loss
2.7% / -3.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
MEX
Country
MX
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
MXN
Market Cap
2830.8B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The latest week was a sharp negative move.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 2,117 MXN -6.4% 2,361 MXN 1,783 MXN -1.01 -12.14 202 Off
5 Jun 2026 2,263 MXN -3.1% 2,366 MXN 1,778 MXN -0.90 -3.79 1.3K Off
29 May 2026 2,335 MXN 0.4% 2,366 MXN 1,772 MXN -1.01 -4.41 50 Off
22 May 2026 2,325 MXN 2.3% 2,362 MXN 1,766 MXN -1.10 -4.56 459 Off
15 May 2026 2,274 MXN 0.2% 2,361 MXN 1,760 MXN -1.08 -6.18 4.0K Off
8 May 2026 2,270 MXN 1.9% 2,360 MXN 1,754 MXN -0.98 -8.87 8 Off
1 May 2026 2,228 MXN -4.0% 2,353 MXN 1,749 MXN -0.59 -7.99 52 Off
24 Apr 2026 2,320 MXN -4.3% 2,346 MXN 1,743 MXN -0.14 -6.27 130 On
17 Apr 2026 2,425 MXN -4.1% 2,338 MXN 1,738 MXN 0.27 -2.92 78 On
10 Apr 2026 2,528 MXN 0.0% 2,326 MXN 1,733 MXN 0.56 0.77 0 On
3 Apr 2026 2,528 MXN 0.0% 2,313 MXN 1,726 MXN 0.78 1.12 0 On
27 Mar 2026 2,528 MXN 0.0% 2,301 MXN 1,720 MXN 0.79 5.26 0 On
20 Mar 2026 2,528 MXN -2.6% 2,286 MXN 1,713 MXN 0.78 9.36 1.1K On
13 Mar 2026 2,596 MXN 5.3% 2,277 MXN 1,706 MXN 0.96 9.48 955 On